- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Chugai Pharmaceutical Co., Ltd. (4519)
"Chugai Pharmaceutical Co., Ltd. stock price live, this page displays TYO 4519 stock exchange data. View the 4519 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Chugai Pharmaceutical Co., Ltd. real time stock price chart below.
What Is the Chugai Pharmaceutical Co., Ltd. Stock Price Today?
The Chugai Pharmaceutical Co., Ltd. stock price today is 40.5500.
What Is the Stock Symbol for Chugai Pharmaceutical Co., Ltd.?
The stock symbol for Chugai Pharmaceutical Co., Ltd. is ""4519.""
What Stock Exchange Does Chugai Pharmaceutical Co., Ltd. Trade On?
Chugai Pharmaceutical Co., Ltd. is listed and trades on the Tokyo stock exchange.
Is Chugai Pharmaceutical Co., Ltd. a Good Stock to Buy?
Determining whether Chugai Pharmaceutical Co., Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4519 quote. (ISIN: JP3519400000)"
What Is the Chugai Pharmaceutical Co., Ltd. Stock Price Today?
The Chugai Pharmaceutical Co., Ltd. stock price today is 40.5500.
What Is the Stock Symbol for Chugai Pharmaceutical Co., Ltd.?
The stock symbol for Chugai Pharmaceutical Co., Ltd. is ""4519.""
What Stock Exchange Does Chugai Pharmaceutical Co., Ltd. Trade On?
Chugai Pharmaceutical Co., Ltd. is listed and trades on the Tokyo stock exchange.
Is Chugai Pharmaceutical Co., Ltd. a Good Stock to Buy?
Determining whether Chugai Pharmaceutical Co., Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4519 quote. (ISIN: JP3519400000)"
40.5500
-0.3100(-0.76%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.5000
40.5500
52 wk Range
26.8700
50.0000
4519 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.500040.5500
52 wk Range
26.870050.0000
Chugai Pharmaceutical Co., Ltd. is currently considered to be trading at Fair valueExplore our list of undervalued stocks for hidden opportunities
Chugai Pharmaceutical Co., Ltd. is not on our AI-picked strategiesExplore current and previous stocks selected by AI
Try Warren AI research assistant for instant insights on Chugai Pharmaceutical Co., Ltd.From metrics, to news, charts, and even a SWOT analysis - you can ask anything!
What you should know about Chugai Pharmaceutical Co., Ltd.Holds more cash than debt on its balance sheetHas raised its dividend for 3 consecutive years
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.47%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.47%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4519 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 3 consecutive years
No news in this category
Looks like there are no results in this news category
Chugai Pharmaceutical Co., Ltd. Company Profile
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Avastin, FoundationOne, Herceptin, Kadcyla, Perjeta, Polivy, Tecentriq, and Phesgo; Actemra for humanized anti-human IL-6 receptor monoclonal antibody; CellCept for immunosuppressant; Edirol, an osteoporosis agent; Enspryng, a pH-dependent binding humanized anti-IL-6 receptor monoclonal antibody; Evrysdi for spinal muscular atrophy agent; Hemlibra, an anti-coagulation factor IXa/X humanized bispecific monoclonal antibody; Mircera, an erythropoiesis-stimulating agent; PiaSky, a pH-dependent binding humanized anti-complement (C5) monoclonal antibody; Ronapreve, an anti-SARS-CoV-2 monoclonal antibody; Tamiflu, an anti-influenza agent; and Vabysmo, an anti VEGF/anti Ang-2 bispecific antibody. The company has strategic alliances and collaboration with Roche Group; and research collaboration and option to license agreement with Araris Biotech AG to develop ADCs using Araris AraLinQ technology. The company was founded in 1925 and is headquartered in Chuo-ku, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.
Compare 4519 to Peers and Sector
Metrics to compare | 4519 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4519PeersSector | |
|---|---|---|---|---|
P/E Ratio | 28.6x | 20.8x | −0.5x | |
PEG Ratio | 1.50 | 0.07 | 0.00 | |
Price/Book | 5.8x | 1.5x | 2.6x | |
Price / LTM Sales | 9.5x | 1.9x | 3.0x | |
Upside (Analyst Target) | - | 8.9% | 53.8% | |
Fair Value Upside | Unlock | 16.7% | 9.6% | Unlock |
People Also Watch
FAQ
What Is the Chugai Pharmaceutical (4519) Stock Price Today?
The Chugai Pharmaceutical stock price today is 40.55
What Stock Exchange Does Chugai Pharmaceutical Trade On?
Chugai Pharmaceutical is listed and trades on the Frankfurt stock exchange.
What Is the Stock Symbol for Chugai Pharmaceutical?
The stock symbol for Chugai Pharmaceutical is "4519."
Does Chugai Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?
The Chugai Pharmaceutical Co., Ltd. dividend yield is 1.47%.
What Is the Chugai Pharmaceutical Market Cap?
As of today, Chugai Pharmaceutical market cap is 68.34B.
What is Chugai Pharmaceutical Earnings Per Share?
The Chugai Pharmaceutical EPS is 235.39.
From a Technical Analysis Perspective, Is 4519 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.